Sofinnova Ventures — 2015 Investments
3 investments dated 2015 · listed companies and verified rows first · show all
eFFECTOR Therapeutics was a clinical-stage biopharmaceutical company.
BiotechSolana Beach, US
Stephen F. Worland, Ph.D.(Executive Officer, Director)Alana McNulty(Executive Officer)
BoardSimeon George(Director)Jonathan Root(Director)inKen Haas(Director)Laurence Lasky(Director)
Board seatMaha Katabi· per SEC Form D · $56M raise · filed Feb 2016
Co-investorsAstellas Venture Management LLCMission Bay CapitalMission BiocapitalOUP (Osage University Partners)Pfizer Venture InvestmentsUS Venture Partners
Hospital-based therapies for acute, life-threatening neurological conditions.
BiotechBerkeley Heights, US
Robert Loch Macdonald(Executive Officer, Director)Brian A. Leuthner(Executive Officer, Director)Andrew Einhorn(Executive Officer)Albert N. Marchio II(Executive Officer)Herbert J. Faleck(Executive Officer)
BoardIsaac Blech(Director)
The site at this domain is a consumer guide to online casinos in Florida, publishing reviews, rankings, and explanations of gambling laws, bonuses, payment methods, and responsible play.
Media & EntertainmentSan Mateo, US
Anukool Lakhina(Executive Officer, Director)
BoardJose Suarez(Director)Amit Shah(Director)Brian Wilcove(Director)Andrew Fligel(Director)Michael LaJoie(Director)
Co-investorsTransLink CapitalArtiman VenturesGoldman SachsIntel CapitalQuestMark PartnersSingTel Innov8 Pte Ltd.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.